Neuroleptic malignant syndrome (NMS) is a rare and life-threatening reaction to the use of almost any kind of neuroleptic (antipsychotic) medication. It causes a high fever and muscle stiffness. Call 911 or go to the nearest hospital if you’re experiencing symptoms of NMS.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Neuroleptic malignant syndrome (NMS) is a rare and life-threatening reaction to the use of any neuroleptic medication. Neuroleptics, also known as antipsychotic medications, treat and manage symptoms of many psychiatric conditions.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
NMS is characterized by the following:
Your autonomic nervous system regulates certain body processes, such as blood pressure and your rate of breathing. Autonomic dysfunction leads to wide swings in blood pressure, excessive sweating (secondary hyperhidrosis) and excessive secretion of saliva (spit).
NMS is potentially life-threatening and requires immediate medical attention in a hospital setting.
Neuroleptics, also known as antipsychotic medications, fall into two classes: first-generation or “typical” antipsychotics and second-generation or “atypical” antipsychotics.
Healthcare providers prescribe first- and second-generation antipsychotics for various neuropsychiatric conditions, including:
The following medications are associated with NMS:
Advertisement
Typical neuroleptic (antipsychotic) medications:
Atypical neuroleptic (antipsychotic) medications:
Antiemetic medications:
Dopaminergic (antiparkinson) medications (from withdrawal):
Malignant hyperthermia is a rare and severe reaction to general anesthesia drugs and muscle relaxants.
Common symptoms include muscle rigidity, slow/decreased reflexes (hyporeflexia) and changes in skin, including bluish discoloration or flushing.
These symptoms may look similar to NMS. However, in most cases, healthcare providers can tell the two conditions apart based on the medical history of the affected person — whether they recently had exposure to an anesthetic or a neuroleptic medication.
Serotonin syndrome is caused by serotonergic agents such as antidepressants, amphetamines, antihistamines and mood stabilizers. Serotonin syndrome happens when there’s too much serotonin in your body.
Symptoms of serotonin syndrome include muscle rigidity, increased/faster reflexes (hyperreflexia), diarrhea, sweating, muscle jerks (myoclonus) and altered mental state. High fever (hyperthermia) and muscle rigidity are usually less severe with serotonin syndrome than with NMS.
Your healthcare provider can distinguish between serotonin syndrome and NMS by both your history and your symptoms.
Neuroleptic malignant syndrome (NMS) can affect anyone taking neuroleptic (antipsychotic) medications.
Although two-thirds of NMS cases are thought to occur within the first week of starting neuroleptic medications, the syndrome may happen at any time during treatment.
Neuroleptic malignant syndrome (NMS) is rare. Approximately 0.01% to 3.2% of people taking neuroleptic (antipsychotic) medications develop NMS.
Cases have been decreasing due to newer medications that are less likely to cause NMS and increased awareness of the syndrome.
Symptoms of neuroleptic malignant syndrome typically develop over one to three days and include:
Advertisement
If you’re experiencing these symptoms, it’s important to call 911 and get medical treatment as soon as possible.
Neuroleptic malignant syndrome (NMS) can happen from a single dose, increasing dose or the same dose of neuroleptic (antipsychotic) medication. NMS is primarily associated with first-generation antipsychotics but can occur, to a lesser degree, with second-generation antipsychotics, antiemetics, and the withdrawal of anti-Parkinson, or dopaminergic, medication.
Scientists are still learning about the exact cause of neuroleptic malignant syndrome (NMS), but it’s currently hypothesized that it’s caused by dopamine D2 receptor antagonism. Dopamine is a neurotransmitter (chemical substance) that acts to convey messages from one cell to another. Neuroleptics block this messenger from entering cells at a specific receptor.
When the dopamine receptors in your hypothalamus and/or your spinal cord are blocked, it causes increased muscle stiffness. The interference with the dopamine receptors in your hypothalamus is also responsible for high fever as well as significant changes in blood pressure, as seen in NMS.
In order for healthcare providers to diagnose NMS, you must have all of the following symptoms or conditions:
Advertisement
In addition, you must have at least two of the following symptoms:
Your healthcare provider may order the following tests if they suspect you have neuroleptic malignant syndrome (NMS):
Neuroleptic malignant syndrome (NMS) is a medical emergency, so quick diagnosis and treatment are essential. If you have NMS, you’ll need to receive care in a hospital setting — most likely an intensive care unit (ICU).
In all cases of NMS, healthcare providers discontinue the use of the neuroleptic (antipsychotic) medication that caused NMS. Treatment also involves treating the symptoms of NMS and preventing complications. Treatments could include:
Advertisement
Risk factors for developing neuroleptic malignant syndrome (NMS) include the initiation (starting) or increase in the dosage of neuroleptic (antipsychotic) medication. The use of more than one neuroleptic medication or lithium also increases the risk. Finally, abrupt cessation (stopping) of a dopaminergic medication (such as a Parkinson’s medication) may cause NMS.
If neuroleptic malignant syndrome (NMS) is diagnosed quickly and treated aggressively and appropriately, most people recover within two to 14 days.
Delayed treatment can result in significant complications, such as muscle, kidney, heart and/or lung issues.
NMS can result in death if it’s not treated quickly enough. The mortality (death) rates for NMS range from 5% to 20%. However, the mortality rate has improved over the past few decades due to awareness of NMS and the use of new antipsychotic medications.
Many people can successfully restart neuroleptic (antipsychotic) medications under guidance from their healthcare provider.
Unfortunately, complications of neuroleptic malignant are common and severe. While some complications result from the characteristic symptoms of NMS and autonomic dysfunction, others, especially infections, may occur from a prolonged stay in an intensive care unit (ICU).
Complications of NMS include:
Because the complications are severe and life-threatening, it’s important to call 911 and seek medical care as soon as possible if you’re experiencing symptoms of NMS. Again, NMS is a life-threatening emergency and may require ICU (intensive care unit) admission.
If you take one or more neuroleptic (antipsychotic), antiemetic and/or dopaminergic (antiparkinson) medications, it’s important to see your healthcare provider regularly to make sure the medication is working for you. It’s also important to ask your healthcare provider about the side effects of the medications you’re taking and what symptoms to look out for.
If you’re experiencing symptoms of neuroleptic malignant syndrome (NMS), such as a very high fever and stiff muscles, it’s absolutely critical to call 911 or get to the nearest hospital as soon as possible. NMS requires immediate medical treatment and can result in death if it’s not treated quickly and properly.
A note from Cleveland Clinic
Neuroleptic malignant syndrome (NMS) is a serious and life-threatening condition, so if you’re experiencing symptoms, getting medical care as soon as possible is crucial. It’s much easier to treat NMS in its early phase. Even though NMS is rare, it’s important to talk to your healthcare provider or pharmacist about side effects and symptoms to look out for if you take neuroleptic (antipsychotic) medications. They’re there to help you.
Last reviewed on 04/12/2022.
Learn more about the Health Library and our editorial process.